The score rose 1 point, mainly due to valuation and price changes. Price fell 1.9%, from $130.69 to $128.18. Reported EPS was unchanged, so the lower price improved valuation support.

The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Historical cheapness: current PE is 11.7× versus the full-history median of 29.6× shown in the valuation table, producing 90.1/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 89.6/100. The model applies a 6.2% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 24.5× (18-month half-life). The favorable scenario uses 13.2× PE and $12 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Business trends are mixed. Over the past year: revenue -10%, operating margin -3.1 percentage points. Free cash flow is 20.3% of revenue. The business score is 45/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $11.97 of EPS and a 13.2× PE, suggesting a share price of about $157.84 — 28% above today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $8.96 of EPS and a 11.2× PE, suggesting a share price of about $100.76 — 18% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.